Preclinical Stocks List
Related Industries: Biotechnology
Related Stock Lists:
Anthrax
Anthrax Vaccines
Biodefense
Biological Warfare
Blood Plasma
Chemical Warfare
Chemical Warfare Agents
Chronic Lymphocytic Leukemia
Decontamination
Drugs
FDA
Graft Versus Host Disease
Host Disease
Inflammatory Bowel Disease
Influenza
Lotion
Lymphocytic Leukemia
Medicine
Monkeypox
Monoclonal Antibody
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
LABD | D | Direxion Daily S&P Biotech Bear 3X Shares | 0.96 | |
SBB | B | ProShares Short SmallCap600 | 0.31 | |
SDD | C | ProShares UltraShort SmallCap600 | 0.31 | |
GERM | C | ETFMG Treatments Testing and Advancements ETF | 0.29 | |
XHYH | A | BondBloxx USD High Yield Bond Healthcare Sector ETF | 0.22 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Anthrax
Anthrax Vaccines
Biodefense
Biological Warfare
Blood Plasma
Chemical Warfare
Chemical Warfare Agents
Chronic Lymphocytic Leukemia
Decontamination
Drugs
FDA
Graft Versus Host Disease
Host Disease
Inflammatory Bowel Disease
Influenza
Lotion
Lymphocytic Leukemia
Medicine
Monkeypox
Monoclonal Antibody
- Preclinical
In drug development, preclinical development, also named preclinical studies and nonclinical studies, is a stage of research that begins before clinical trials (testing in humans) can begin, and during which important feasibility, iterative testing and drug safety data are collected.
The main goals of pre-clinical studies are to determine the safe dose for first-in-man study and assess a product's safety profile. Products may include new medical devices, drugs, gene therapy solutions and diagnostic tools.
On average, only one in every 5,000 compounds that enters drug discovery to the stage of preclinical development becomes an approved drug.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles